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Rab27A regulates transport of lysosome-related organelles (LROs) and release of secretory granules in
various types of cells. Here, we identified up-regulation of Rab27A during differentiation of osteoclasts
(OCLs) from bone-marrow macrophages (BMMs), by DNA microarray analysis. Rab27A deficiency in
OCLs, using small interfering RNA (siRNA) knockdown in RAW-D cell line or BMMs derived from ashen
mice, which display genetic defects in Rab27A expression, induced multinucleated and giant cells. Upon
stimulation with macrophage-colony stimulating factor (M-CSF) and receptor activator of nuclear factor
kappa-B ligand (RANKL), essential cytokines for OCL differentiation, phosphorylation levels of
extracellular signal-regulated kinase (Erk), proto-oncogene tyrosine-protein kinase (Src), and p-38 were
slightly enhanced in ashen BMMs than in wild-type BMMs. The cell surface level of c-fms, an M-CSF
receptor, was slightly higher in ashen BMMs than in wild-type BMMs, and down-regulation of RANK, a
RANKL receptor, was delayed. In addition to receptors, OCLs derived from ashen mice exhibited aberrant
actin ring formation, abnormal subcellular localization of lysosome-associatedmembrane protein (LAMP2)
and cathepsin K (CTSK), and marked reduction in resorbing activity. Thus, these findings suggest that
Rab27A regulates normal transport of cell surface receptors modulating multinucleation and LROs in
OCLs.
T he Rab family of small GTPases mediates membrane trafficking events such as vesicle formation, vesiclemovement andmembrane fusion1. Amember of this family, Rab27A, has been extensively studied2. Griscellisyndrome type 2 is a genetic disorder affecting Rab27A in humans, and it is characterized by hypopigmenta-
tion of the skin and eyes, immunodeficiency3,4. Rab27A is widely expressed on secretory granules in various
secretory cells, such as endocrine and exocrine cells and various leukocytes5. Rab27A is particularly involved in
regulation of transport of ‘‘lysosome-related organelles (LROs)’’6,7. LROs resemble morphologically lysosomes
with electron-dense protein deposits, and containmost lysosomal proteins, and have a low luminal pH. However,
they display many distinct morphological, functional, and compositional characteristics8. LROs include the
melanosomes in melanocytes9, lytic granules in lymphocytes3,10, delta granules in platelets11, and ‘‘secretory’’
lysosomes in osteoclasts (OCLs)12. Compared to the other LROs, the transport mechanisms of LROs in OCLs are
not well known.
OCLs are multinucleated giant cells that mainly participate in bone resorption13,14. OCLs are formed by the
fusion of mononuclear progenitors of the monocyte/macrophage lineage15. When OCLs undergo bone resorp-
tion, they form a specialized LRO, termed as the ‘‘ruffled border’’16,17. The ruffled border generates an acidic
extracellular microenvironment called as resorption lacuna, which is surrounded by an actin ring18. Several acid
hydrolases are secreted in the resorption lacuna, which is formed on the bone surface19. Among these acid
hydrolases, cathepsin K (CTSK) and tartrate-resistant acid phosphatase (TRAP, also known as ACP5) are highly
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collagen, the major component of bone matrix20–22. TRAP is a
metallo-phosphoesterase involved in bone matrix degradation, and
removal of mannose 6-phosphate (Man-6-P) residues from acid
hydrolases23,24. However, the detailed transport mechanisms of
LROs in OCLs are yet to be elucidated. In addition, the extent of
involvement of Rab27A in the transport of LROs in OCLs is still
unclear.
In this study, we identified the up-regulation of Rab27A during
OCL differentiation from bone-marrow macrophages (BMMs),
using DNA microarray analysis. Moreover, we have demonstrated,
by knock-down using small interfering RNA (siRNA) and the
Rab27A-deficient ashen mice, that Rab27A regulates the transport
of LROs and cell surface receptors, therebymodulating the cell size in
OCLs.
Results
Expression of Rab27A increases during OCL differentiation. To
identify a gene which regulates membrane trafficking during OCL
differentiation, we performed DNA microarray analysis. Total RNA
was obtained from BMMs treated with M-CSF (30 ng/ml) and
RANKL (50 ng/ml), and cultured for 72 h on a plastic surface or a
dentin slice. We observed that the OCLs cultured on the plastic
surface were differentiated rapidly into OCL rather than on the
dentin slice. Therefore, we compared the mRNA levels of OCLs
cultured under the two different conditions. Of the total of 40,130
genes identified during the analysis, 1,363 were up-regulated and 881
genes were down-regulated. Indeed, OCL marker genes such as
calcitonin receptor (CTR), cathepsin K (CTSK), transmembrane 7
superfamily member 4 (DC-STAMP), carbonic anhydrase 2, and
TRAP were up-regulated (Supplementary Figure S1A). Among the
several up-regulated genes, we focused on Rab27A, since Rab27A
expression showed an increased, but that of Rab27B decreased
during OCL differentiation.
We further measured the mRNA levels of Rab27A and Rab27B in
MC3T3-E1 cells (murine osteoblastic precursor cell line), RAW-D
cells (sub-clone of the murine macrophage cell line RAW264.7, which
has a high capacity for differentiation into OCLs)25, and RANKL-
stimulated RAW-D cells (OCLs). Quantitative real-time PCR analysis
showed that the mRNA level of Rab27A in RAW-D cells was a 4.5-
fold higher than that in MC3TC-E1 cells (Supplementary Figure
S1B). Moreover, upon stimulation with RANKL, the Rab27A
mRNA expression in mature OCLs was significantly increased com-
pared to that in unstimulated RAW-D cells (Supplementary Figure
S1B). However, the mRNA levels of Rab27B in RAW-D and OCLs
were not detectable (Supplementary Figure S1B). Thus, we concluded
that Rab27A expression was significantly increased during differenti-
ation from macrophages into OCLs.
Rab27A is localized in lysosomes in RAW-D cells. We next
determined the subcellular localization of Rab27A in RAW-D cells.
Since the staining pattern of endogenous Rab27A in the OCL
precursor cell RAW-D and RANKL-stimulated OCLs differentiated
from RAW-D cells, with several anti-Rab27A antibodies was obscure,
we analyzed overexpression of Rab27A-Green Fluorescent Protein
(GFP) in RAW-D cells. We compared the localization of Rab27A
against several organelle marker proteins. As shown in Sup-
plementary Figure S2, the Rab27A-GFP protein was extensively
colocalized with LAMP2 (late endosomes/lysosomes), but not with
GM130 (Golgi) and calnexin (endoplasmic reticulum; ER). These
results indicate that Rab27A is localized in the lysosomes and late
endosomes in RAW-D cells.
Knockdown of Rab27A causes formation of multinucleated, giant
OCLs.To explore the role of Rab27A during OCL differentiation, we
performed knockdown by siRNA transfection in RANKL-stimulated
RAW-D cells. We determined the knockdown efficiency of Rab27A
in the RAW-D derived OCLs (Fig. 1A). Rab27A siRNA potently
inhibited its expression level down to approximately 40% as
compared to that obtained from a control siRNA (Fig. 1a). Under
these conditions, Rab27A depletion induced considerably distinct
morphological characteristics in OCLs such as multinucleated
and giant cells, when both the cells were cultured for 72 h after
stimulation with RANKL (Fig. 1b). A total nucleus number count
in TRAP-positive multinucleated cells transfected with the control
siRNA and Rab27A siRNA showed a higher nucleus number in
Rab27A depleted OCLs, compared to that seen in the control
OCLs (Fig. 1c). This suggests that the control cells largely remained
as TRAP-negative mononuclear cells (Fig. 1c). However, the number
of TRAP positive multinucleated OCLs was not different between
the control and Rab27A knockdown OCLs (Fig. 1d). These results
indicate that Rab27A depletion in OCLs induce multinucleation and
larger cell formation.
OCLs derived fromRab27A-deficient (ashen)mice displaysmulti-
nucleation and giant cell formation. Given the importance of
Rab27A in osteoclastogenesis, we compared the phenotypes of
OCL differentiation in BMMs derived from ashen mice, which
show genetic defects in Rab27A expression, and control mice10,26.
The BMMs were cultured with media containing M-CSF and
RANKL, essential cytokines for OCL maturation, for 5, 6, 7, and 8
days. TRAP staining revealed that OCLs from ashenmice exhibited a
markedly bigger size compared to OCLs from the wild-type mice
(Fig. 2a). The number of TRAP-positive cells was higher in ashen
mice than that of thewild-typemice at all the indicated days (Fig. 2b).
Further, we counted the nuclear number of the OCLs following
nuclear staining with DAPI (Fig. 2c). The OCLs from ashen mice
containing more than 11 nuclei accounted for approximately 50% of
the total number, whereas those from the wild-type did for only
approximately 10% (Fig. 2d). A calculation of the cell area of OCLs
from wild-type and ashenmice at 8 days showed a higher cell area in
ashen mice than in wild-type mice (Fig. 2e).
Partially enhanced maturation of ashen OCL. To examine the
differences between wild-type and ashen OCLs, we compared
mRNA levels of various OCL marker genes in wild-type and ashen
OCLs. As shown in Fig. 3, quantitative real-time PCR revealed that
mRNA levels of RANK, c-fms, CTR, DC-STAMP, OC-STAMP,
and CTSK were significantly higher in ashen OCLs compared to
wild-type OCLs. However, the levels of integrin b3 and Src were
indistinguishable in wild-type and ashen OCLs. (Fig. 3). These
results indicate the partially enhancement of marker gene
expression in ashen OCLs compared to wild-type OCLs.
Enhanced signaling of M-CSF and RANKL in OCLs from ashen
mice. To investigate molecular mechanisms responsible for larger
size of OCLs from ashen mice, we tested the signaling levels
between wild-type and ashen BMMs, which are OCL precursor
cells, by stimulation with M-CSF or RANKL. When stimulated
with a concentration of M-CSF (10 ng/ml), the phosphorylation
levels of Erk, p-38 and Src were slightly enhanced in ashen BMMs
compared to wild-type cells (Fig. 4a). However, the phosphorylation
levels of Akt were indistinguishable between wild-type and ashen
BMMs (Fig. 4a). Upon stimulation with RANKL (50 ng/ml), the
phosphorylation levels of Erk, p-38 and Akt in ashen BMMs were
increased compared to wild-type cells (Fig. 4b). These results indicate
that the enhanced signaling as a result of M-CSF and RANKL
stimulation is probably one of the major factors responsible for
larger size in ashen OCLs than in the wild-type OCLs.
Increased protein levels of c-fms (MCSF receptor) and RANK
(RANKL receptor) in ashen OCLs. The mechanisms of enhanced
signaling in ashenOCLs compared to wild-type OCLswere analyzed.
First, the total protein levels of c-fms (M-CSF receptor), and RANK
www.nature.com/scientificreports
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(RANKL receptor) in the precursor BMMs and mature OCLs were
determined. We observed that the expression level of c-fms in ashen
BMMs was higher than in wild-type BMMs (Fig. 5a). Densitometric
analysis of these proteins also showed that the levels of c-fms in ashen
BMMs or OCLs were significantly increased as compared to wild-
type BMMs (Fig. 5b). However, RANK protein levels between wild-
type and ashen BMMs were comparable (Fig. 5a, b). Interestingly,
during differentiation of BMMs into mature OCLs, the expression
levels of c-fms and RANK were significantly up-regulated in ashen
OCLs compared to those in wild-type OCLs (Fig 5c, d).
We also investigated the surface expression levels of c-fms and
RANK by flow cytometory (Fig. 5 e, f). The surface expression of c-
fms was slightly higher in ashen BMMs than that observed in wild-type
BMMs (Fig. 5e). However, the surface expression of RANK in ashen
BMMs was comparable, but rather slightly lower than that observed in
wild-type BMMs (Fig 5f). These results indicate that the enhanced
signaling of c-fms in ashen cells is probably due to abnormal transport,
accumulation and/or slightly increased surface expression levels.
Since we did not determine the mechanisms of the enhanced
signaling of RANK in ashen BMMs, we further examined the pos-
sibility of down-regulation of RANK. Following stimulation with
RANKL, the fate of the receptor was determined by western blotting
(Fig. 5g). The cellular RANK in wild-type BMMs was gradually
degraded for 4 h (Fig. 5g). In contrast, in ashen BMMs, the protein
levels of RANK were rather increased at approximately 1–4 h
(Fig. 5g). To evaluate the effects of lysosomal degradation of
RANK, the protein levels of RANK after the ligand stimulation were
determined by western blotting in the presence or absence of prote-
ase inhibitors such as E-64d, a cysteine protease inhibitor, and pep-
statin, an aspartic protease inhibitor (Fig. 5h). However, apparent
differences were not observed between inwild-type and ashenBMMs
(Fig. 5h). These results indicate that Rab27A deficiency caused the
partially abnormal down-regulation or transport of RANK, but not
abnormal receptor degradation by the lysosomes.
Taken together, we concluded that Rab27A deficiency in OCLs
caused the enhanced M-CSF and RANKL signaling through
Figure 1 | Knockdown of Rab27A in RAW-D derivedOCLs after stimulation with RANKL. (a) Knockdown efficiency wasmeasured bymRNA levels of
Rab27A. After incubation with 10 p mol siRNA for 24 h, cells were cultured for additional for 5 days in the presence of RANKL (50ng/mL). (b) RAW-D
cells were transfected with either a control siRNA or a siRNA specific for Rab27A. After stimulation with RANKL (50 ng/mL) for 72 h, OCLs were analyzed
by TRAP-staining. (c) Total nucleus number of TRAP positive multinucleated OCLs, but not TRAP negative mononucleated cells following a 72 h
culture, was counted per viewing field. ** P, 0.01. (D) The number of TRAP-positive multinucleated OCLs per viewing field was counted. Bar: 50 mm.
www.nature.com/scientificreports
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abnormal transport of their respective receptors, c-fms and RANK
and/or other adaptor proteins of these receptors.
Abnormal actin ring formation and altered localization of LAMP2
and CTSK in ashen OCLs. To determine whether Rab27A affects the
transport of endosomes/lysosomes in OCLs or not, we analyzed
actin-ring formation and subcellular localization of LAMP2 in
wild-type and ashen OCLs on non-coated glass slip. We observed
an ovary-shape and clear form in the actin-ring formation of wild-
type OCLs, whereas ashen OCLs displayed an irregular shape and
unclear form (Fig. 6a). The subcellular distribution of LAMP2
in wild-type OCLs was seen in various punctate structures located
within the actin ring (Fig. 6a). However, the staining patterns showed
two different localizations of LAMP2 in ashen OCLs: irregular-
shaped punctate structures along the actin-ring distant from the
nuclei (Fig. 6a, the upper panel), and those located predominantly
around the nuclei (Fig. 6a, the lower panel). We also determined the
subcellular localization of CTSK in wild-type and ashen OCLs. In
wild-type OCLs, the staining of CTSK was detected in punctate
structures within the central cytoplasm around the nuclei (Fig. 6b).
However, in ashen OCLs, the subcellular localization of CTSK was
predominantly present in the area circumscribed by the peripheral
actin ring, although it was detected in various punctate structures
around the multiple nuclei (Fig. 6b).
To further observe on distribution of OCLs on dentin or bone slice,
we performed alternative experiments on vitronectin-coated glass
coverslips. Recently, Szewczyk et al. reported that the distribution
of F-actin and lysosomal proteins in OCLs is very similar on bone
slice and vitronectin-coated glass coverslips27. On vitronectin, ashen
OCLs displayed more irregular shape of F-actin formation than wild-
type OCLs (Fig. 6c, d), although the localizations of LAMP2 between
wild-type and ashen OCLs were not so different (Fig. 6c, 6d).
However, the localization of CTSK was exclusively around the nuclei
in ashen OCLs, whereas that was detected in the central cytoplasm in
wild-type OCLs. The results also indicate that the abnormal transport
of LROs in ashen OCLs compared to wild-type OCLs.
Figure 2 | Phenotypes of OCLs derived from control mice (wild-type) and ashen mice. (a) BMMs derived from wild-type and ashenmice were cultured
withM-CSF (10 ng/ml) and RANKL (50 ng/ml) for the indicated days. The cells were fixed and stained for TRAP. Bar: 50 mm. (b) The number of TRAP-
positive multinucleated cells was counted at each indicated day. (c) The cells were fixed and stained with nuclear staining DAPI. Bar: 50 mm. (d) the
nuclear numbers were counted and classified as 5 , 10 (white bar), 11 , 50 (gray bar), or more than 50 (black bar). (e) The individual cell area was
analyzed by using the BZ analyzer software, dynamic cell count system (Keyence).
www.nature.com/scientificreports
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Endosomal/lysosomal proteins in ashen OCLs are perturbed. The
levels of various endosomal/lysosomal proteins in OCLs were
determined by western blot analysis of wild-type and ashen OCL
cell lysates. The expression level of LAMP-2 protein in ashen
OCLs was lower than that in wild-type OCLs, although it was not
statistically significant (Fig. 7). In contrast, the EEA1 and cathepsin
D, (lysosomal aspartic protease), protein levels in ashen OCLs were
higher than those in wild-type OCLs (Fig. 7). However, CTSK
expression levels between wild-type and in ashen OCLs were
similar (Fig. 7). In addition to lysosomal proteins, we found that
expression of integrin b3, (OCL marker protein present in the
plasma membrane) was significantly higher in ashen OCLs than
that in wild-type OCLs (Fig. 7). On the other hand, the levels of
Src, a cytosolic OCL marker protein, between wild-type and ashen
OCLs were similar (Fig. 7). It should be noted that the protein
expression of integrin b3 in ashen OCLs was highly increased
compared with wild-type OCLs (Fig. 7), but the mRNA level of
integrin b3 in ashen OCLs was comparable to wild-type OCLs
(Fig. 3), suggesting that transport and/or degradation rate of
integrin b3 between wild-type and ashen OCLs may be different.
Thus, the expression levels of various endosomal/lysosomal
proteins were perturbed in ashen OCLs compared to those in
wild-type OCLs.
Impaired bone resorption activity in ashenOCLs. Finally, the bone
resorption activity of OCLs was analyzed by a pit formation assay,
usingOCLs derived fromwild-type and ashenmice. After comparing
the resorption pit area, ashen OCLs exhibited a marked reduction
in the resorbing activity, while wild-type OCLs had a moderate
resorbing activity (Fig. 8a, b). Taken together, we concluded that
the OCLs from ashen mice express an abnormal lysosome function.
Discussion
In this study, we have demonstrated the increase in Rab27A express-
ion during OCL differentiation. Studies on siRNA knockdown in
RAW-D cells or BMMs derived from ashen mice showed that
Rab27A deficiency in OCLs is responsible for induction of multi-
nucleation and giant cell formation. Stimulation with M-CSF or
RANKL caused enhanced phosphorylation levels of Erk, p-38, and
Src in ashen OCLs compared to wild-type OCLs. The ashen OCLs
exhibited marked reduction in the bone resorbing activity and
abnormal lysosome localization, indicating that Rab27A deficiency
caused abnormal transport of LROs in the OCLs.
Rab27A-deficient OCLs were larger in size and multinucleated.
This phenotype is probably due to the enhancement of several sig-
naling pathways through cell surface receptors such as c-fms and
RANK. Indeed, we observed increased phosphorylation levels of
Erk, p-38 and Src signaling thorough the M-CSF c-fms complex,
and Erk, p-38, and Akt signaling through the RANKL-RANK com-
plex in Rab27A-deficient OCLs. This phenotype is reminiscent of
Vps35 deficiency in OCLs28. Vps35 is a critical essential component
of the retromer protein complex that regulates transmembrane pro-
teins from the endosomes to the Golgi apparatus. Vps35-deficient
OCLs shows a larger cell size and aremultinucleated due to enhanced
RANK signaling28. In such a case, increased cell surface levels of
RANK in Vps35-deficient OCLs causes enhanced RANK signaling,
resulting in larger cell size and multinucleation. However, in case of
Rab27A-deficient OCLs, the surface level of RANK was comparable
to that of wild-type cells. On the other hand, the cell surface level of c-
fms was increased in these cells compared to wild-type OCLs. One
possible explanation that normal RANK surface level with enhanced
RANKL signaling in Rab27-deficient OCLs is continuous remaining
of RANK on endosomes. Alternatively, abnormal transport of
adaptor proteins of RANK (e.g.TRAF6) in Rab27-deficient OCLs
may cause the enhanced signaling.
Rab27A-deficient OCLs shows a markedly impaired bone resorp-
tion activity. Bone resorption is a complex process combining secre-
tion of protons by the vacuolar H1-ATPase and various lysosomal
enzymes, and endocytosis/transcytosis of the degraded products via
vesicle transport from apical to basolateral membrane29. Previous
studies with various leukocytes have shown that Rab27A is involved
in both exocytosis/secretion and endocytosis/phagocytosis30-32.
Rab27A-deficient neutrophils33,34, eosinophils35, basophils36 all show
impaired exocytosis. In contrast, receptor-mediated phagocytosis is
enhanced in Rab27A-deficient macrophages. Rab27A-deficient
dendritic cells show increased phagosome acidification and antigen
Figure 3 | Comparison ofmRNA levels of variousmarker proteinsOCLs fromwild-type and ashenmice.BMMs derived fromwild-type and ashenmice
were cultured with M-CSF (10 ng/ml) and RANKL (50 ng/ml) for 5 days. After isolation of mRNA in these cells, real-time PCR was performed.
**P , 0.01, *P , 0.05 for the indicated comparisons.
www.nature.com/scientificreports
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degradation, causing a defect in antigen cross-presentation30. Thus,
Rab27A mediated-bone resorption may be quite different mechan-
isms to its phagocytosis.
The LAMP2 distribution was observed in two different regions in
ashenOCLs; the peripheral region along the actin-ring, and the peri-
nuclear region. Similarly, CTSK was predominantly detected in the
similar peripheral region in ashen OCLs. Contrastingly, the distri-
bution of LAMP2 and CTSK in wild-type OCLs was seen in various
punctate structures within the actin ring, which is consistent with
previous results37. The abnormal lysosomal protein distribution and
severely impaired bone resorption activity in ashen OCLs suggests
that Rab27A probably regulates cellular distribution and secretion of
LROs in OCLs.
Rab27A is speculated to play a unique role in OCLs, since its
depletion results in different phenotypes compared to that expressed
during deletion of other Rab proteins in OCLs. Rab3, for example, is
involved in regulated exocytosis in secretory cells such as neurons
and neuroendocrine cells, whose characteristics are similar to those
of Rab27A2. Rab3D is the Rab3 isoform predominantly expressed in
OCLs. Although Rab3D-deficient OCLs exhibit an abnormal ruffled
border, the localization of Rab3D in the post-TGN (trans-Golgi net-
work) vesicles and not in the OCL lysosomes, suggests that Rab3D
may regulate the biogenesis of a secretory compartment in the
TGN38. Rab7 in OCLs is thought to be implicated in the formation
of ruffled borders38. Rab7-gene knockdown experiments using anti-
sense oligo-deoxynucleotides have revealed that Rab7 is required for
polarization of ruffled border formation, as well as bone resorption
by OCLs via transport of V-ATPase to the ruffled border mem-
brane38. Rab13 is up-regulated during differentiation of human peri-
pheral blood monocytic cells into OCLs39. Since Rab13 is localized in
vesicles between the trans-Golgi network and basolateral membrane
domain, it is not involved in endocytosis or transcytosis of bone
degradation products39. Rab38 is involved in sorting of protein to
the melanosome in melanocytes, and phagosomal maturation
in macrophages. However, OCLs derived from Rab38-deficient
(Chocolate) mice show no phenotype, indicating redundant func-
tion(s) of other Rab protein(s)40. Considering the findings about
other rab proteins in OCLs and our results, it is speculated that
Rab27A may have redundant function of Rab38 in OCLs.
The role of Rab27A/B in osteoblasts has been reported.
Suppression of Rab27A or RAb27B by RNA interference causes
markedly reduced secretion of RANKL in murine osteoblastic cell
line ST2 cells41. These results also suggest that Rab27deficiency in
osteoblasts results in reduced OCL activation.
In conclusion, this study shows that Rab27A deficiency causes an
abnormal transport of LROs in OCLs. Moreover, Rab27A deficiency
Figure 4 | Comparison of signaling levels of OCLs fromwild-type and ashenmice. (a) BMMs fromwild-type and ashenmice were pre-incubated for 2 h
in serum free media in the absence of M-CSF. After M-CSF addition, the cells were incubated for the indicated times, and consequently harvested. The
same protein amounts of cell lysates were subjected to SDS-PAGE followed by western blotting with antibodies against p-Erk, p-p38, p-Src, p-Akt,
and GAPDH. (b) BMMs fromwild-type and ashenmice were pre-incubated for 2 h in serum free media in the absence of RANKL. After adding RANKL,
the cells were incubated for the indicated times, consequently harvested. The same protein amounts of cell lysates were subjected to SDS-PAGE followed
by western blotting with antibodies to p-Erk, p-p38, p-Akt, and GAPDH.
www.nature.com/scientificreports
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shows the increased surface level of c-fms, and the delayed down-
regulation of RANK in ashen cells, resulting in enhanced signaling of
M-CSF and RANKL.
Methods
Antibodies and reagents. Macrophage colony stimulating factor (M-CSF) was
purchased from Kyowa Hakko Kogyo (Tokyo, Japan). Recombinant receptor
activator of nuclear factor kappa-B ligand (RANKL) was prepared as described
previously42. Antibodies (Abs) were purchased as follows: Rabbit polyclonal
anti-GM130 (Cat. NO. PM061) and, Rabbit polyclonal anti-Calnexin (Cat.No.
PM060) were from MBL (Nagoya, Japan). Rat monoclonal anti-LAMP2 (Cat. No.
1921-01) were from Southern Biotechnology Inc, Birmingham, AL, USA. Mouse
monoclonal anti-Src (proto-oncogene tyrosine-protein kinase) (Cat. No. 05-184,
Upstate Biotechnology, Lake Placid, NY, USA). Rabbit polyclonal anti-c-fms (colony-
stimulating factor 1 receptor) (Cat. No. sc-692), Rabbit polyclonal anti-RANK
(receptor activator of nuclear factor kappa-B) (Cat. No. sc-9072), and mouse
monoclonal anti-NFATc1 (nuclear factor of activated T-cells, cytoplasmic 1) (Cat.
No. sc-7294) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Abs
specific for phospho-Erk1/2 (extracellular signal-regulated kinase) (Cat. No. 9101S,
Thr202/Tyr204), phospho-Akt (protein kinase B) (Cat. No. 9271S, Ser473), phospho-
Figure 5 | Expression levels of RANK and c-fms in BMMs orOCLs fromwild-type and ashenmice.BMMswere prepared as per themethod described in
‘‘Experimental Procedures’’. The OCLs were further differentiated from BMMs cultured with RANKL (50 ng/ml) and M-CSF (30 ng/ml) for the 72 h.
The same protein amounts of BMM-lysates (a) or OCL-lysates (c) were subjected to SDS-PAGE followed by western blotting with antibodies against
RANK, c-fms, andGAPDH. (b, d). Densitometric analysis for the quantification of each protein in the cell lysate of both cell types. The relative levels were
defined as the chemiluminescence intensity per mm2 measured by LAS4000-mini. The data are represented as the mean 6 S.D. of values from four
independent experiments. *P, 0.05, **P, 0.01 for the indicated comparison. (e, f) Flow cytometric analysis of surface levels of c-fms (e) or RANK (f) in
BMMs. The cells were stained for cell surface with specific antibody against c-fms or RANK, and subsequently stained with a second antibody conjugated
with PE. Data are representative of four independent experiments. (g) Down-regulation of RANK in BMMs from wild-type and ashen mice. Both the
BMMswere treated with RANKL (50 ng/ml), and further incubated at 37uC for the indicated times. The cell lysates were subjected to SDS-PAGE followed
by western blotting with antibodies against RANK and GAPDH. (h) Degradation of RANK by lysosomes in BMMs from wild-type and ashenmice. Both
the BMMswere treated withRANKL (50 ng/ml), and further incubated at 37uC in the absence or presence of E-64 (10micro g/ml) and pepstain (10micro
g/ml) for the indicated times. The cell lysates were subjected to SDS-PAGE followed by western blotting with antibodies against RANK and GAPDH.
www.nature.com/scientificreports
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p38 (Cat. No. 9211S, Thr180/Tyr182,) and phospho-Src (Cat No. 2105S, Tyr527)
were from Cell Signaling Technology (Danvers, MA, USA). Rabbit polyclonal Anti-
Rab27A/B from Immuno Biological Laboratories Ltd. (Takasaki, Japan). Rabbit
polyclonal anti-cathepsin D or cathepsin K was prepared as described previously43,44.
The Osteo Assay Plate was from Corning (Corning, NY, USA). All other reagents,
including phenylmethylsulfonyl fluoride and the protease inhibitor cocktail, were
from Sigma-Aldrich (Saint-Louis, MO, USA). Alexa Fluor 488 goat anti-rabbit IgG
and Alexa Fluor 555 goat anti-rat IgG were from Molecular Probes/Invitrogen
(Eugene, Oregon, USA).
Animals. The ash/ash (C3H/He background) and control C3H/He mice described
previously were originally provided by N.A. Jenkins (National Cancer Institute,
Frederick, Maryland, USA)45. All animals were maintained according to the
guidelines offset by the Japanese Pharmacological Society. All animals, their handling,
and experiments were approved by the Animal Research Committee of the Graduate
School of Biomedical Sciences, Nagasaki University.
Cell culture. Isolation of BMMs was performed according to a previously described
method46. Briefly, marrow cells were cultured from mice femurs and tibias overnight
in a-minimal essential medium (a-MEM) (Wako Pure Chemicals, Osaka, Japan)
containing 10% fetal bovine serum (FBS), supplemented with 100 U/ml of penicillin
and 100 mg/ml of streptomycin in the presence of M-CSF (10 ng/ml) at 37 uC in 5%
CO2. The non-adherent cells were harvested; stroma-free bone marrow cells were
cultured in the presence of 10 ng/ml of M-CSF. After 4 days, the non-adherent cells
were washed out, and the adherent cells were used as BMMs. The BMMs were
replated, and then further cultured with new medium containing M-CSF (10 ng/ml)
and RANKL (50 ng/ml) for the times indicated.
mRNA expression profiling of OCL differentiation by Affymetrix Microarray. To
identify the up-regulated genes during OCL differentiation, we utilized
the Affymetrix microarray system (Affymetrix, Santa Clara, CA, USA). The data were
obtained from BMMs cultured for 72 h on a plastic surface (rapid differentiation)
and a dentin slice (slow differentiation) withM-CSF (30 ng/ml) and RANKL (50 mg/
ml) were compared. Total RNA from the two types of BMMs were isolated with
Trizol Reagent (Invitrogen, Carlsbad, USA). The samples were further purified
using the RNeasy Mini Kit (QIAGEN, Tokyo, Japan) as per the manufacturer’s
instructions. The hybridized microarray gene chip arrays were analyzed
according to the manufacturer’s instructions and scanned by an Affymetrix
Scanner.
Immunofluorescence microscopy. Immunocytochemistry was performed as
described previously43. Briefly, the cells were grown on glass cover slips and fixed with
4.0% paraformaldehyde in PBS for 30 min at room temperature. The fixed cells were
then washed with 50 mMNH4Cl in PBS for quenching, and permeabilized with 0.2%
Tween-20 in PBS for 10 min. The cells were incubated with 0.2% gelatin in PBS for
1 h, and subsequently incubated overnight at 4uC with primary antibodies. After
washing, the cells were stained by second antibodies such as Alexa Fluor 488 goat
anti-rabbit IgG or Alexa Fluor 594 (Cell Signaling Technology, Danvers, MA, USA)
goat anti-rabbit IgG. Actin cytoskeleton staining with Alexa 594-phalloidin
(Invitrogen) or nuclear staining with 49,6-diamidino-2-phenylindole (DAPI,
Invitrogen Carlsbad, CA, USA) was performed. The samples were subjected to
microscopy using a laser-scanning confocal imaging system (LSM510, 710 or 780
META; Carl Zeiss, AG, Jena, Germany).
Quantitative RT-PCR. Total RNA was isolated with Trizol Reagent, and reverse
transcription was performed using oligo(dT)15 primer (Promega) and Revertra Ace
(Toyobo, Osaka, Japan). Quantitative real-time PCR was performed using a
MX3005P QPCR system (Agilent Technology, La Jolla, CA, USA). cDNA was
amplified using Brilliant III Ultra-Fast SYBR QPCR Master Mix (Agilent
Technology) according to the manufacturer’s instructions. The following primer sets
were used: GAPDH forward, AAATGGTGAAGGTCGGTGTG; GAPDH reverse,
TGAAGGGGTCGTTGATGG; Rab27A forward, TTCCTGCTTCTGTTCGACCT;
Rab27A reverse, GGCAGCACTGGTTTCAAAAT; Rab27B forward, GATGGAG-
ACTATGATTATCTG; Rab27B reverse, TCCATTGACAGTGTCCGGAACC;
RANK forward, CTTGGACACCTGGAATGAAGAAG; RANK reverse,
AGGGCCTTGCCTGCATC; c-fms forward, TTGGACTGGCTAGGGACATC; c-
fms reverse, GGTTCAGACCAAGCGAGAAG; DC-STAMP forward, CTAGCTG-
GCTGGACTTCATCC; DC-STAMP reverse, TCATGCTGTCTAGGAGACCTC;
OC-STAMP forward, TGGGCCTCCATATGACCTCGAGTAG; OC-STAMP
reverse, TCAAAGGCTTGTAAATTGGAGGAGT; CTSK forward, CAGCTTCC-
CCAAGATGTGAT; CTSK reverse, AGCACCAACGAGAGGAGAAA; Integrin b3
forward, TGTGTGCCTGGTGCTCAGA; Integrin b3 reverse, AGCAGGTTC-
TCCTTCAGGTTACA; Src forward, AGAGTGCTGAGCGACCTGTGT; Src
reverse, GCAGAGATGCTGCCTTGGTT; CTR forward, CGCATCCGC-
TTGAATGTG; CTR reverse, TCTGTCTTTCCCCAGGAAATGA.
Transient transfection of RAW-D cells. RAW-D cells were cultured in a-MEM
supplemented with 10% FBS. All cells were maintained in a 70% confluent at 37uC in
an incubator containing 5% CO2, and transiently transfected with pEGFP-C1-Rab27A
Figure 6 | Immunofluorescence observation of actin ring formation and lysosomal proteins in OCLs from wild-type and ashen mice. The cells on
cover-glass were fixed, permeabilized with 0.3% Tween-20 in PBS, and then allowed to react with phalloidin for F-actin (red) or antibodies for lysosomal
proteins (green). After washing, the samples were incubated with a fluorescence-labeled secondary antibody and then were visualized by confocal laser
microscopy. (a) On non-coated glass slip, LAMP-2 antibody. (b) On non-coated glass slip, CTSK antibody. (c) On vitronectin-coated glass slip, LAMP-2
antibody. (d) On vitronectin-coated glass slip, CTSK antibody. Bar: 50 mm.
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using SuperFectTM Transfection Reagent (Quiagen, Germany) according to the
manufacture’s protocol.
Flow cytometry analysis. The cell suspension (2 3 106 cells/100 ml) was incubated
on ice for 20 min with primary antibodies appropriately diluted with PBS containing
1% normal goat serum. Samples were preincubated with Fc Block (anti-mouse CD16/
CD32 antibody) (BD Pharmigen), and subsequently with specific antibodies or
control antibodies RANK (anti-mouse CD265-PE conjugated) or c-fms (anti-mouse
CD115-PE conjugated) or isotype control (rat IgG2a k-PE conjugated) for 15 min on
ice. Flow cytometric analyses were performed on a BD FACS Verse Cytometer.
TRAP staining method. The cells were fixed with 4% paraformaldehyde and stained
for TRAP activity using a previously described method47 TRAP-positive cells with 3
or more nuclei were regarded as mature osteoclasts. Murine monocytic cell line
RAW-D cells, were kindly provided by Prof. Toshio Kukita (Kyushu University,
Japan) and cultured in a-MEM containing 10% FBS with RANKL (50 ng/ml)25 were
used for this experiment.
Small interfering RNA (siRNA). siRNA experiments in OCLs were performed as
described previously48. The target sequence of murine Rab27A siRNA was:
GGACUUAAUCAUCTAAGAGAAUGGAA (Rab27A siRNA). Briefly, RAW-D
cells plated at 5 3 104 cells on 60-mm plates were cultured in the presence of
RANKL in antibiotic-free media. The siRNA was transfected into RAW-D cells
using Lipofectamine RNAiMAXTM transfection reagent (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions. BLOCK-iTTM Alexa
Fluor Red Fluorescent Oligo (Life Technologies, Carlsbad, CA, USA) was used to
optimize the delivery of siRNA. The cells were incubated with 10 pmol of
siRNA for 24 h. For TRAP staining, the cells were incubated for an additional 5
days.
Bone resorption assay. The bone-resorbing activity of OCLs was determined using
the Osteo Assay Stripwell Plate for 5 days of culture. Images for cell area, bone
resorption area, and nuclei counting were taken with anal-in-one type fluorescence
microscope BZ-9000 (Keyence). Deconvolution for the cell and bone resorption area
was analyzed by using the BZ analyzer software, dynamic cell count system
(Keyence).
RANK degradation assays. OCLs were grown in a 3.5 cm dish, and incubated in a-
MEM supplemented with 0.1% BSA lacking FBS for 2 h. Following this, they were
incubated with 50 ng/ml of RANKL for the indicated period. The cells were harvested
with a cell lysis buffer (50 mM Tris-HCl (pH 8.0), 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride and
proteinase inhibitor cocktail).
Western blot analysis. BMMs were stimulated with or without RANKL in the
presence ofM-CSF for the indicated amount of time. Cells were rinsed twice with ice-
cold PBS, and lysed in a cell lysis buffer (50 mMTris-HCl [pH 8.0], 1%Nonidet P-40,
0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM PMSF, and proteinase
inhibitor cocktail). The protein concentration of each sample was measured with
BCA Protein Assay Reagent (Thermo Pierce, Rockford, IL, USA) according to the
manufacturer’s instructions. Five micrograms of lysate protein was applied to each
lane. Following SDS-PAGE, proteins were electroblotted onto a polyvinylidene
difluoride membrane. The blots were blocked with 3% skim milk/TBS (Tris-buffered
saline)-0.1%Tween for 1 h at room temperature, probed with primary antibodies
overnight at 4uC. They were then washed, and incubated with HRP-conjugated
secondary antibodies. These were finally detected with ECL-prime (GE Healthcare
Life Sciences, Little Chalfont, UK). The immunoreactive bands were analyzed using
the LAS4000-mini (Fuji Photo Film, Tokyo, Japan).
Statistical analysis. Quantitative data are presented as means 6 standard deviation
(S.D.). The Tukey-Kramer method was used to identify differences between
Figure 7 | Lysosomal function in OCLs from wild-type and ashen mice.
(a) BMMs were prepared by the method described in ‘‘Experimental
Procedures’’. The OCLs were further differentiated BMMs that were
cultured with RANKL (50 ng/ml) and M-CSF (10 ng/ml) for 6 days. The
same protein amounts of OCL-lysates were subjected to SDS-PAGE
followed by western blotting with antibodies to LAMP2, EEA1, cathepsin
D (CTSD), CTSK, integrin b3, Src, and GAPDH. (b) Densitometric
analysis for the quantification of each protein in the cell lysate of both cell
types. The relative levels were defined as the chemiluminescence intensity
per mm2 measured by LAS4000-mini. The data are presented as the mean
6 S.D. of values from four independent experiments. **P , 0.01 for the
indicated comparison.
Figure 8 | Bone resorption activity of OCLs from wild-type and ashen
mice. (a)Photograph of the bone-resorption activity of OCLs from
wild-type and ashen mice. (b) The bone resorption area was analyzed by
using the BZ analyzer software, dynamic cell count system (Keyence). Data
are presented as s the mean 6 S.D. of three independent experiments.
**P , 0.01 for the indicated comparisons.
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concentrations when ANOVA indicated that a significant difference (*P , 0.05 or
**P , 0.01) existed.
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